Ramon Coronil (@coronilRMD) header
Ramon Coronil (@coronilRMD) profile picture

Médico Radiólogo | imágenes Oncológicas y GU | Radiologist Oncologic & GU Imagining 🇦🇷

Buenos Aires, Argentina
Joined August 2020
Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)Photo by Ramon Coronil (@coronilRMD)
¡¡¡¡CLUB ESTUDIANTES DE LA PLATA!!!!!🔥🇦🇹
317
2,468
106
13,513
189,099
Ramon Coronil retweeted
Ayúdenme a difundirlo. @MandingaTattoo
3
3
434
Ramon Coronil retweeted
Thrilled to share #PRIMARY2 Trial Results. This is the first randomised trial to show that adding [⁶⁸Ga]Ga-PSMA-11 PET-CT to MRI can safely halve the number of men needing a prostate biopsy. Hot off the press in @TheLancetOncol 🎉 In 660 men across Australian sites with PI-RADS 2-3 but high clinical risk, PSMA-PET: - Avoided biopsy in nearly half (49%) - Was non-inferior for detecting clinically significant cancer (12% vs 16%) - Halved the overdiagnosis of insignificant cancer (32% to 14%) Fewer biopsies, less overdiagnosis, whilst not missing clinically significant prostate cancer: a real step forward for the diagnostic pathway. Enormous congratulations to @ButeauJames @PeterMacCC , who led this as the centrepiece of his PhD and presented it as a plenary at #EAU26 in London. And to my brilliant co-lead @drlouiseemmett - this was a true partnership across our two centres. Thank you to the UROLOGISTS @DrDanielMoon @declangmurphy (& many others), nuclear medicine physicians, technologists, radiopharmaceutical scientists across every site, and to @AnnetteVDHeyden and the @pros_tic who held it all together. We are grateful to our funders: @PCF_Science, @nhmrc, St Vincent's Curran Foundation, Peter MacCallum Cancer Foundation, and @ANZUPtrials Most of all, thank you to the 660 men who took part. Open Access article: thelancet.com/journals/lanon…
8
59
4
115
13,317
Ramon Coronil retweeted
Step into a complete 4-week journey in prostate MRI: 📍 Week 1: PI-RADS & pitfalls 📍 Week 2: Advanced PI-RADS & real AI-assisted cases 📍 Week 3: Active Surveillance with PRECISE v2 📍 Week 4: Recurrence & post-treatment MRI (PI-RR) 📲 More info: quodemy.com/en
5
6
279
Ramon Coronil retweeted
📚 ¿Quieres ampliar tus conocimientos en RM de recto y conducto anal? Súmate a este webinar gratuito junto a la Dra. María Florencia Bambaci 📅 19 de junio - 19 hs (España peninsular) CEST / UTC+2 💻 Modalidad online y gratuita 🔗 Inscríbete en quodemy.com/registro-webinar…
2
2
129
Ramon Coronil retweeted
First images from the GE Omni 128 cm Total Body PET/CT 🚀 The new scanner detected a <5 mm local recurrence of prostate cancer missed by standard PSMA PET/CT - despite 79% shorter acquisition ⏱️ Delayed imaging boosted lesion uptake and informed dose-painted salvage RT 🎯 @JournalofNucMed @PeterMacCC @declangmurphy @_ShankarSiva jnm.snmjournals.org/content/…
5
45
3
172
22,365
Ramon Coronil retweeted
MRI before prostatectomy isn’t just staging… it’s prognostic. New meta-analysis in JAMA Oncology shows MRI predicts outcomes independently. 🧵 📌 Study: Pretreatment MRI as prognostic factor after radical prostatectomy 📊 40 studies | 24,941 patients 👨‍⚕️ Population Men undergoing radical prostatectomy with pre-treatment MRI ⚔️ Key MRI features → Strong outcome predictors 🔴 Extraprostatic extension (mrT3a) •BCR: HR 2.16 •Metastasis: HR 3.18 •Cancer-specific mortality: HR 10.9 (!!) 🔴 Seminal vesicle invasion (mrT3b) •BCR: HR 2.74 •Metastasis: HR 5.58 📊 Quantitative MRI also matters •PI-RADS 4–5 → HR ~2.1 •Tumor ≥20 mm → HR ~2.35 •Low ADC → HR ~2.4 💡 Key insight MRI adds independent prognostic value beyond PSA, Gleason, and pathology 👉 Not just imaging 👉 A biologic risk signal before surgery ⚠️ Practice-changing angle MRI T-staging may be stronger than DRE-based clinical staging → Enables better pre-op risk stratification → Potential for treatment intensification / de-escalation 🎯 Takeaway If you’re still using MRI only for staging… You’re underusing it MRI = prognosis + decision-making tool 🔖 Save this for clinic discussions 📖 Full paper in comment ⬇️ #OncoTwitter #MedTwitter #ProstateCancer #UroOncology @OncoAlert @myesmo @esmo_open @asco
3
43
2
140
9,599
Ramon Coronil retweeted
El PET PSMA estadifica correctamente. Alto volumen 40ml or 110ml? PSMA PET stages accurately. High volume: 40 mL or 110 mL? @piet_ost @APCCC_Lugano
4
9
329
⭐ UroTerag LATAM APCCC 2026. Adaptando la evidencia al contexto de América Latina @OncoAlert #APCCC26 @APCCC_Lugano @Silke_Gillessen @Martin_AngelMD @DBarreiro4 @jpsade2 @DrMHofman @dandanmena @Cdanicas @raymanneh 🚨 Detección precoz en cáncer de próstata en LATAM: tiempo de actuar 🔹 Implementar estrategias de screening en países de ingresos bajos y medios 🔹 Integrar programas en sistemas de salud 🔹 Rol clave de atención primaria + urología 🔹 PSA como herramienta central 🌎 Desigualdad global en acceso sigue siendo crítica 📊 Propuesta: 🔹 Screening desde los 50 años (antes en alto riesgo) 🔹 Seguimiento basado en PSA 🔹 MRI en evaluación urológica ⚠️ Hoy vemos más enfermedad metastásica de la que deberíamos 💡 Tratar enfermedad avanzada cuesta lo mismo que curar precozmente 👉 Time for action #APCCC26 #ProstateCancer #LATAM #Oncology
9
14
938
⭐ Are we overtreating patients in the mpMRI / PSMA PET era? @OncoAlert @APCCC_Lugano #APCCC26 @Silke_Gillessen @AOmlin Presented by Derya Tilki 🔹 Excellent overview on the strengths and limits of modern imaging 🔹 Key messages: 🔹 1. MRI-derived EPE and seminal vesicle invasion are independently associated with biochemical recurrence and metastatic failure 🔹 2. MRI-based T-staging remains clinically useful — but terminology and reporting need standardization 🔹 3. PSMA PET/CT improves detection of local tumor extension and nodal disease in selected settings 🔹 4. Combining mpMRI + PSMA PET may better define dominant and non-dominant lesions 🔹 5. Imaging–biopsy discordance remains a key challenge in treatment planning 🔹 6. More accurate imaging can improve selection — but may also increase the risk of overtreatment if not interpreted carefully 🔹 Take-home: Modern imaging should refine decisions, not replace clinical judgment, pathology and multidisciplinary discussion. @declangmurphy @RenuEapen @DrYukselUrun @fabioturco92 @UrsulaVogl @SScagliarini @Tylersbrt @neerajaiims @amerseburger @Cdanicas @AarmstrongDuke @BertrandTOMBAL @ChrisSweens1 @EAntonarakis @KOSJ12 @VedangMurthy @DrRanaMcKay @LoebStacy @stefanofanti4 @mirrorsmed @profkhermann @dr_coops @piet_ost @_ShankarSiva @DrSpratticus @scocmem @AmandaNizamMD @tompowles1 @brian_rini @Uromigos @EUplatinum @EANM_NucMed @ESTRO_RT @Uroweb
1
36
1
80
4,439
Ramon Coronil retweeted
Randomized comparison of MRI versus transurethral resection for staging new #BladderCancers: Final survival analysis from the #BladderPath trial. Presentation by James Catto, PhD @sheffielduni. #EAU26 written coverage by @zklaassen_md @GACancerCenter > bit.ly/41ef6H3 @Uroweb
1
14
37
3,086
Ramon Coronil retweeted
PFS following primary staging with 18F-PSMA-1007-PET/CT vs 18NaF-PET/CT in #ProstateCancer: Results from the PRISMA-PET randomized controlled trial. Presentation by Karen Buch-Olsen. #EAU26 written coverage by @zklaassen_md > bit.ly/4lpvoWS @Uroweb
6
9
882
Ramon Coronil retweeted
🚨 Gamechanger #PRIMARY2 RCT #EAU26, presented and in press @TheLancetOncol. PSMA-PET CT in men with equivocal or -ve MRI but red flags results reduces biopsy by 49% and has non-inferior csPCa detection to template biopsy in all. Proud to be part of this🚨
1
44
1
97
5,862
1er curso de Diagnóstico y tratamiento mínimamente invasivo de cáncer de próstata.
50
Ramon Coronil retweeted
👏🏻📣 ¡Buena noticia! Debido a las solicitudes recibidas extendemos la fecha de inscripción de nuestro fellow "Resonancia Magnética Prostática". 📲 Ingresa en quodemy.com
2
5
105
2026 Genitourinary Oncology Spring Refresher - Dry Run Updates in the management of cancers of the prostate, bladder, kidney, testes, from @NCCN @ASTRO_org @ESTRO_RT @Uroweb #Radonc residents @ARRO_org, I hope it helps you ace the board exams! youtu.be/IOQB79eXWH8
1
31
2
99
24,826
#GU26 Dr. Armstrong presents PCWG4: modernizing prostate cancer trial design 🧭 Updated clinical states model (2016–2025 panel) 🔬 Integrates PSMA PET, ctDNA, CTCs & molecular subtyping 🔹 New imaging-specific rPFS incl. serial PSMA PET guidance 🔹 Standardized delay/prevent endpoints + biomarker timing 🎯 Patient-centric, biology-driven framework for ADT-sensitive & resistant states ✅ PCWG4 sets the roadmap for the PET era @ASCO @UroToday
8
14
836
Ramon Coronil retweeted
Daro-PET: A phase 2 trial of darolutamide to enhance PSMA expression in patients with localized #ProstateCancer. Presentation by @motajmsc @Icesp_. #GU26 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4sie08Z @ASCO
2
6
11
503
Ramon Coronil retweeted
👏🏻 Felicitamos a Juan de la Morena @juandelamorena_ ganador de la inscripción para nuestro fellowship virtual "Resonancia Magnética Prostática". Todo para la práctica asistencial". 💙 ¡Gracias a todos por participar!
2
3
66